• 1. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409

5,7-Dimethyl-1H-indole-4-carbonitrile (CAS No. 1190319-95-9): A Key Intermediate in Modern Pharmaceutical Synthesis

5,7-Dimethyl-1H-indole-4-carbonitrile, identified by its CAS number 1190319-95-9, is a versatile heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry. This compound serves as a crucial intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and inflammatory disorders. Its unique structural framework, featuring a nitrile group and methyl substituents at the 5th and 7th positions of the indole ring, makes it a valuable building block for medicinal chemists.

The indole core is a well-documented pharmacophore in drug discovery, with numerous therapeutic applications ranging from antimicrobial to anticancer agents. The introduction of a nitrile group at the 4-position enhances the compound's reactivity, enabling further functionalization through nucleophilic addition or reduction reactions. This property is particularly useful in constructing more complex molecules with tailored biological activities.

In recent years, 5,7-Dimethyl-1H-indole-4-carbonitrile has been explored in the development of novel treatments for neurodegenerative diseases. Studies have demonstrated its potential as a precursor for indole derivatives that modulate neurotransmitter pathways, offering promising leads for drugs targeting conditions such as Alzheimer's and Parkinson's disease. The methyl groups at the 5th and 7th positions contribute to the stability of the indole ring while allowing for selective modifications at other sites, making it an ideal candidate for structure-activity relationship (SAR) studies.

The compound's role in inflammation research is equally noteworthy. Researchers have identified that certain indole derivatives derived from 5,7-Dimethyl-1H-indole-4-carbonitrile exhibit anti-inflammatory properties by inhibiting key signaling pathways involved in immune responses. These findings align with the growing interest in indole-based compounds as potential therapeutics for chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The synthesis of 5,7-Dimethyl-1H-indole-4-carbonitrile typically involves multi-step organic transformations starting from readily available precursors. One common approach involves the condensation of acetophenone derivatives with ammonia or ammonium cyanide, followed by cyclization and methylation steps to introduce the desired substituents. Advances in catalytic methods have further optimized these processes, improving yield and reducing environmental impact.

The chemical properties of 5,7-Dimethyl-1H-indole-4-carbonitrile make it amenable to various synthetic strategies. The nitrile group can be converted into amides or carboxylic acids through hydrolysis, while palladium-catalyzed cross-coupling reactions allow for the introduction of aryl or alkenyl groups. These transformations enable the construction of diverse molecular architectures, facilitating the discovery of new drug candidates.

In industrial settings, the production of 5,7-Dimethyl-1H-indole-4-carbonitrile is often scaled up to meet pharmaceutical demand. Quality control measures are stringent to ensure purity and consistency, with analytical techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy employed for characterization. These practices underscore the importance of process optimization and regulatory compliance in pharmaceutical manufacturing.

The future prospects of 5,7-Dimethyl-1H-indole-4-carbonitrile in drug development are promising. Ongoing research aims to expand its applications in oncology and infectious diseases by designing novel derivatives with enhanced efficacy and reduced side effects. Collaborative efforts between academic institutions and pharmaceutical companies are likely to drive innovation in this area, leveraging computational modeling and high-throughput screening technologies.

In conclusion, 5,7-Dimethyl-1H-indole-4-carbonitrile (CAS No. 1190319-95-9) represents a cornerstone in modern pharmaceutical synthesis. Its structural versatility and biological relevance position it as a critical intermediate for developing next-generation therapeutics. As research continues to uncover new applications for indole-based compounds, this compound will undoubtedly remain at the forefront of medicinal chemistry innovation.

• 63124-09-4(3,4-Quinolinedicarbonitrile)
• 816448-91-6(8-methylquinoline-4-carbonitrile)
• 3613-06-7(3-Methyl-1H-indole-5-carbonitrile)
• 5457-28-3(1H-indole-3-carbonitrile)
• 194490-13-6(1H-Indole-3-carbonitrile,5-methyl-)
• 671215-70-6(1H-Indole-5-carbonitrile,4-methyl-(9CI))
• 36193-83-6(1H-Benz[g]indole-3-carbonitrile)
• 74316-57-7(5-Quinolinecarbonitrile, 8-methyl-)
• 194490-22-7(1H-Indole-3-carbonitrile,7-methyl-)
• 194490-23-8(6-methyl-1H-Indole-3-carbonitrile)